Halozyme Therapeutics | HALO - Ação





Ação Alterar Data
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amarin USD 183.58M 12.32M 2026-03
Amgen USD 6.19B 39M 2026-03
Baxter International USD 2.32B 84M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
MannKind USD 49.17M 13.85M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Pfizer USD 10.67B 13M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
United Therapeutics USD 178.3M 4.8M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12